Plasmodium falciparum acid basic repeat antigen (ABRA) peptides: Erythrocyte binding and biological activity

Vaccine

Volumn 19, Issue 31, 2001, Pages 4496-4504

  Curtidor, H ^a   Urquiza, M ^a   Suarez, J E ^a   Rodriguez, L E ^a   Ocampo, M ^a   Puentes, A ^a   Garcia, J E ^a   Vera, R ^a   Lopez R ^a   Ramirez, L E ^a   Pinzon, M ^a   Patarroyo, M E ^a  

^a UNIVERSIDAD NACIONAL DE COLOMBIA   (Colombia)

Author keywords

ABRA; Binding peptides; Plasmodium falciparum

Indexed keywords

BINDING PROTEIN; GLUTAMINYLLYSYLTYROSYLGLUTAMINYLGLUTAMYLVALYLASPARAGINYLASPARTYLGLUTAMYLASP ARTYLASPARTYLVALYLASPARAGINYLASPARTYLGLUTAMYLGLUTAMYLASPARTYLTHREONYLASPARAGINYL ASPARTIC ACID; LEUCYLGLUTAMINYLSERYLHISTIDYLLYSYLLYSYLLEUCYLISOLEUCYLLYSYLALANYLLEUCYLLYSY LLYSYLASPARAGINYLISOLEUCYLGLUTAMYLSERYLTYROSYLGLUTAMINYLASPARAGINE; LYSYLLYSYLHISTIDYLLEUCYLISOLEUCYLTYROSYLLYSYLASPARAGINYLLYSYLSERYLTYROSYLAS PARAGINYLPROLYLLEUCYLLEUCYLLEUCYLSERYLCYSTEINYLVALYLLYSINE; LYSYLMETHIONYLASPARAGINYLMETHIONYLLEUCYLLYSYLGLUTAMYLASPARAGINYLVALYLASPART YLTYROSYLISOLEUCYLGLUTAMINYLLYSYLASPARAGINYLGLUTAMINYLASPARAGINYLLEUCYLPHENYLALA NYLLYSINE; PROTOZOAL PROTEIN; TYROSYLLYSYLSERYLGLUTAMINYLGLYCYLHISTIDYLLYSYLLYSYLGLUTAMYLTHREONYLSERYLGLU TAMINYLASPARAGINYLGLUTAMINYLASPARAGINYLGLUTAMYLASPARAGINYLASPARAGINYLASPARTYLASP ARAGINE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANTIMICROBIAL ACTIVITY; ARTICLE; BINDING SITE; BIOASSAY; CELL INVASION; CONTROLLED STUDY; DIAGNOSTIC TEST; DRUG ACTIVITY; DRUG RECEPTOR BINDING; ERYTHROCYTE; HEMOLYSIS; HOST PARASITE INTERACTION; IN VITRO STUDY; MEROZOITE; NONHUMAN; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PROTEIN LOCALIZATION;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, PROTOZOAN; ERYTHROCYTES; HUMANS; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PLASMODIUM FALCIPARUM; PROTEIN BINDING; PROTOZOAN PROTEINS;

EID: 0035859993     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(01)00202-X     Document Type: Article

References (27)

1. Primary structure of a Plasmodium falciparum malaria antigen located at the merozoite surface an within the parasitophorous vacuole
2. Sorting large numbers of clones expressing Plasmodium falciparum antigens in Escherichia coli by differential antibody screening
3. Plasmodium falciparum antigens synthesized by schizonts and stabilized at the merozoite surface by antibodies when schizonts mature in the presence of growth inhibitory serum
4. Monoclonal antibody characterization of Plasmodium falciparum antigens in immune complexes formed when schizonts rupture in the presence of immune serum
5. Characterization of protective epitopes in a highly conserved Plasmodium falciparum antigenic protein containing repeats of acidic and basic residues
6. Plasmodium falciparum: Chymotryptic-like proteolysis associated with a 101-kDa acid-basic repeat antigen
7. A Trichomonas vaginalis cDNA with partial protein sequence homology with a Plasmodium falciparum excreted protein ABRA
8. Expression and characterisation of Plasmodium falciparum acid basic repeat antigen expressed in Escherichia coli
9. Plasmodium falciparum: Protease inhibitors and inhibition of erythrocyte invasion
10. A role for erythrocyte band 3 degradation by the parasite gp 76 serine protease in the formation of the parasitophorous vacuole during invasion of erythrocytes by Plasmodium falciparum
11. Molecular cloning and expression of human Ca(+2)-sensitive cytosolic phospholipase A2
12. Solid phase peptide synthesis. I. The synthesis of a tetrapeptide
13. General method for the rapid solid phase synthesis of large numbers of peptides: Specificity of antigen antibody interaction at the level of individual aminoacids
14. SN2 deprotection of synthetic peptides with a low concentration of HF in dimethyl sulfide: Evidence and application in peptide synthesis
15. Identification of Plasmodium falciparum MSP-1 peptides able to bind to human red blood cells
16. Plasmodium falciparum EBA-175 KDa protein peptides which bind to human red blood cells
17. A GBP 130 derived peptide from Plasmodium falciparum binds to human erythrocytes and inhibits merozoite invasion in vitro
18. Two MSA-2 peptides that bind to human red blood cells are relevant to Plasmodium falciparum merozoite invasion
19. A Plasmodium falciparum hemolytic activity
20. Addition and omission analogs of the 13-residue antibacterial and hemolytic peptide PKLLKTFLSKWIG (structural preferences, model membrane binding and biological activities)
21. Proteases of protozoan parasites
22. Identification of a novel antigenic domain of Plasmodium falciparum merozoite surface protein-1 that specifically binds to human erythrocytes and inhibits parasite invasion, in vitro
23. Selective cytotoxicity of Dermaseptin S3 toward intraerythrocytic Plasmodium falciparum and the underlying molecular basis
24. Inhibition of P. falciparum phospholipase A2 by chloroquine, quinine and arteether
25. Modification of host cell membrane lipid composition by the intra-erythrocytic human malaria Plasmodium falciparum